CoChat

High concentrations of illicit stimulants and cutting agents cause false positives on fentanyl test strips

Open access

Published version of a preprint

The DOI matches its Crossref record; 23 of the 24 references it cites were found in a registry or an index.

Abstract

Background: The opioid epidemic has caused an increase in overdose deaths which can be attributed to fentanyl combined with various illicit substances. Drug checking programs have been started by many harm reduction groups to provide tools for users to determine the composition of their street drugs. Immunoassay fentanyl test strips (FTS) allow users to test drugs for fentanyl by either filling a baggie or cooker with water to dissolve the sample and test. The antibody used in FTS is very selective for fentanyl at high dilutions, a characteristic of the traditional use of urine testing. These street sample preparation methods can lead to mg/mL concentrations of several potential interferents. We tested whether these concentrated samples could cause false positive results on a FTS. Methods: 20 ng/mL Rapid Response FTS were obtained from BTNX Inc. and tested against 4 different pharmaceuticals (diphenhydramine, alprazolam, gabapentin, and naloxone buprenorphine) and 3 illicit stimulants [cocaine HCl, methamphetamine, and 3,4-methylenedioxymethamphetamine (MDMA)] in concentrations from 20 to 0.2 mg/mL. The FTS testing pad is divided into 2 sections: the control area and the test area. Control and test area signal intensities were quantified by ImageJ from photographs of the test strips and compared to a threshold set by fentanyl at the FTS limit of detection. Results: False positive results indicating the presence of fentanyl were obtained from samples of methamphetamine, MDMA, and diphenhydramine at concentrations at or above 1 mg/mL. Diphenhydramine is a common cutting agent in heroin. The street sample preparation protocols for FTS use suggested by many online resources would produce such concentrations of these materials. Street samples need to be diluted more significantly to avoid interference from potential cutting agents and stimulants. Conclusions: Fentanyl test strips are commercially available, successful at detecting fentanyl to the specified limit of detection and can be a valuable tool for harm reduction efforts. Users should be aware that when drugs and adulterants are in high concentrations, FTS can give a false positive result.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12954-021-00478-4

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 FTS with fentanyl standard: FTS ran with fentanyl standard at 125 ng/mL (a), 100 ng/mL (b), 83 ng/mL (c), 63 ng/mL (d), 50 ng/mL (e), 25 ng/mL (f), and 5 ng/mL (g). Fentanyl threshold line determined to be at 25 ng/mL correlating to 1152 counts (SD = 72)
Fig. 1 FTS with fentanyl standard: FTS ran with fentanyl standard at 125 ng/mL (a), 100 ng/mL (b), 83 ng/mL (c), 63 ng/mL (d), 50 ng/mL (e), 25 ng/mL (f), and 5 ng/mL (g). Fentanyl threshold line determined to be at 25 ng/mL correlating to 1152 counts (SD = 72)CC BY · PubMed Central
Fig. 2 Fentanyl test strip images of interference compounds: FTS were ran with water, cocaine, methamphetamine, MDMA, diphenhydramine capsules, and diphenhydramine tablets and were photographed after 5 min. The testing bar (right side of testing pad) for moderately concentrated samples (approximately > 2 mg/mL) of methamphetamine, MDMA, diphenhydramine capsules, diphenhydramine tablets did not appear indicating false positives
Fig. 2 Fentanyl test strip images of interference compounds: FTS were ran with water, cocaine, methamphetamine, MDMA, diphenhydramine capsules, and diphenhydramine tablets and were photographed after 5 min. The testing bar (right side of testing pad) for moderately concentrated samples (approximately > 2 mg/mL) of methamphetamine, MDMA, diphenhydramine capsules, diphenhydramine tablets did not appear indicating false positivesCC BY · PubMed Central
Fig. 3 Illicit stimulants, fillers, and blanks: samples with intensities below the red line are likely to be mistaken for fentanyl. Sub-graphs for each substance that crosses the fentanyl threshold line are included with error bars for multiple measurements
Fig. 3 Illicit stimulants, fillers, and blanks: samples with intensities below the red line are likely to be mistaken for fentanyl. Sub-graphs for each substance that crosses the fentanyl threshold line are included with error bars for multiple measurementsCC BY · PubMed Central
Fig. 4 Color development of control and test bars for water and fentanyl: A–J: Water, Panels a–j: 1 mg/mL Fentanyl standard. A/a: testing pad prior to solution saturation; Panel B/b, 10 s after solution reached testing pad; Panel C/c, 20 s; Panel D/d, 30 s, Panel E/e, 40 s; Panel F/f, 50 s; Panel G/g, 60 s; Panel H/h, 120 s; Panel I/i, 240 s, Panel J/j, 420 s
Fig. 4 Color development of control and test bars for water and fentanyl: A–J: Water, Panels a–j: 1 mg/mL Fentanyl standard. A/a: testing pad prior to solution saturation; Panel B/b, 10 s after solution reached testing pad; Panel C/c, 20 s; Panel D/d, 30 s, Panel E/e, 40 s; Panel F/f, 50 s; Panel G/g, 60 s; Panel H/h, 120 s; Panel I/i, 240 s, Panel J/j, 420 sCC BY · PubMed Central
Fig. 5 Development time for fentanyl test strip control and test bars: FTS were tested in DI water and 1 mg/mL fentanyl standard. Photographs were taken every 5 s of test strips up to 420 s. The integrated intensities of the control and test bars were analyzed using ImageJ
Fig. 5 Development time for fentanyl test strip control and test bars: FTS were tested in DI water and 1 mg/mL fentanyl standard. Photographs were taken every 5 s of test strips up to 420 s. The integrated intensities of the control and test bars were analyzed using ImageJCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Research works printed but not linked: 2

  1. Hunt N, Ashton M, Lenton S, Mitcheson L, Nelles B. A review of the evidence-base for harm reduction approaches to drug use. PLoS ONE. 2006;3(1):16–30.
  2. BTNX Inc. Rapid Response SIngle Drug Test Strip Product Insert, pp. 3–5

Cited by

See all 91

Metadata

Authors
Lockwood, T.-L. E., Vervoordt, A., & Lieberman, M.
Affiliations
University of Notre Dame (US)
Corresponding author
Lockwood, Tracy-Lynn E.
Venue
Harm Reduction Journal
Published
2021-03-09
Volume
18
Issue
1
Pages
30-30
ISSN
1477-7517 (ISSN-L)
OpenAlex
W3134216738
Cited by
85
References
24
Citations by year
2026: 5 · 2025: 19 · 2024: 24 · 2023: 21 · 2022: 15 · 2021: 1
FWCI
9.94
Type
journal article
Language
en
Open access
Licence
Locations
  • Harm Reduction Journal (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Center for Advancing Translational Sciences (UL1TR002529)
  • Advanced Diagnostics and Therapeutics (Substance Abuse Discovery Fund)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
Keywords
fentanyl test strips, false positives, drug adulterants, cutting agents, illicit stimulants, methamphetamine, MDMA, diphenhydramine, sample preparation, immunoassay interference, harm reduction, drug checking, opioid overdose, heroin
MeSH terms
Analgesics, Opioid, Heroin, Drug Contamination, False Positive Reactions, Fentanyl, Humans, Opioid-Related Disorders, Illicit Drugs, Drug Overdose

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: High concentrations of illicit stimulants and cutting agents cause false positives on fentanyl test strips. https://app.cochat.ai/papers/10.1186/s12954-021-00478-4
The paper
Lockwood, T.-L. E., Vervoordt, A., & Lieberman, M. (2021). High concentrations of illicit stimulants and cutting agents cause false positives on fentanyl test strips. Harm Reduction Journal. https://doi.org/10.1186/s12954-021-00478-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.